Clinical trial
A Multicenter, Randomized, Open-Label, Controlled, Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects (The Ignite Study)
NCT01764386 is registered in ClinicalTrials.gov with Orexigen Therapeutics, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Open-Label, Controlled, Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects (The Ignite Study)
- Lead sponsor
- Orexigen Therapeutics, Inc
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 28, 2013
- Completion date
- September 30, 2014
- Enrollment
- 242 (actual)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.